Autoimmune Diseases

Pharmacists must keep up to date with the latest in irritable bowel syndrome management.

At the virtual Scientific Sessions for the American Diabetes Association, a study shows that metformin can improve adolescent type 1 diabetes.

A study presented during a poster session at the American Diabetes Association Virtual 81st Scientific Sessions evaluated performance, safety, and satisfaction of an extended-wear insulin infusion set in patients with type 1 diabetes.

Aducanumab (Aduhelm; Biogen) is the first approved novel treatment for Alzheimer disease since 2003.

Exposure to heat and sun can worsen symptoms for certain conditions.

Pharmacists can play an important role as part of an interdisciplinary team in treating patients with rheumatoid arthritis.

Tremfya phase 3 data shows skin clearance rates were maintained at 5 years with 55.5% of patients achieving an IGA score of 0% and 53% achieving PASI 100 response in VOYAGE 2 trial.

Research presented at Academy of Managed Care Pharmacy’s 2021 virtual conference evaluated tolerance and adherence to oral disease-modifying therapies for relapsing-remitting multiple sclerosis.

AbbVie submitted an application to the FDA for the use of risankizumab-rzaa, 150 mg (Skyrizi) in adults with active psoriatic arthritis.

Ponesimod was shown to be superior to teriflunomide in the rate of confirmed relapses and the number of new or enlarged T1 and T2 lesions.

Pharmacists can play an important role as part of the interdisciplinary care team.

Preliminary findings suggest patients with multiple sclerosis who are taking cladribine can mount and maintain effective vaccine responses.

Pharmacists can advise patients on how to control symptoms and reduce exacerbations.

The intramuscular administration of peginterferon beta-1a (Plegridy; Biogen) offers patients with relapsing multiple sclerosis a new treatment option.

Voclosporin (Lupkynis; Aurinia Pharmaceuticals) is indicated in combination with a background immunosuppressive therapy for the treatment of active lupus nephritis in adults.

Here are some of the top-read FDA approvals covered by Drug Topics® from this year.

Prefilled syringes have been the way that many children with juvenile idiopathic arthritis get their methotrexate. A pilot study examines if prefilled pens might be a better option.

Pharmacists can play an integral role in educating patients about nutrition and lifestyle factors.

Results of 2 recent studies suggested a higher risk of developing osteoporosis in patients with inflammatory bowel disease.

An overview of the use of satralizumab-mwge (Enspryng; Genentech) in neuromyelitis optica spectrum disorder (NMOSD).

Two lots of the thyroid tablets are being recalled after testing found the lots to be subpotent.

Higher cumulative exposure to systemic antibiotic therapy may be associated with a greater risk of new-onset inflammatory bowel disease.

Pharmacists can play an important role in educating patients about autoimmune drugs to prevent medication errors.

Levodopa/carbidopa is currently the gold standard for controlling motor symptoms associated with Parkinson disease.

Ofatumumab (Kesimpta; Novartis) is the first and only self-administered, targeted B-cell therapy for the treatment of relapsing multiple sclerosis.

The therapy received fast track designation and was approved in just over 1 year.

A Kawasaki-like inflammatory disease has affected children who have coronavirus disease 2019.

The data from a new study has shown that investigational, long-acting injectable cabotegravir boasted a 66% higher efficacy than daily oral pills in preventing HIV-1.

A new study found increased plaque buildup levels in women with HIV who also suffered from persistent depression and stress.